Javascript must be enabled to continue!
Innate Immunity and Autoimmune Diseases
View through CrossRef
The innate immune response is responsible for the initial defense against invading pathogens and signs of damage; in turn, it activates the adaptive immune response to result in highly specific and lasting immunity, mediated by the clonal expansion of antigen-specific B and T lymphocytes. Inflammation is the acute response to infection and tissue damage to limit aggression to the body. It is a complex reaction of vascularized tissues to infection, toxin exposure or cell injury that includes extravasation of plasma proteins and leukocytes. Paradoxically, uncontrolled and prolonged inflammation can result in secondary damage and the development of immune pathology in the host. The components of the innate immune system have recently been studied as responsible mechanisms in various chronic diseases such as diabetes mellitus, atherosclerosis, asthma and allergies, among others. Autoimmune disease is an attack on auto tissues by the adaptation of the immune system. In general, such diseases are characterized by autoantibodies and/or autoreactive lymphocytes directed at antigens against themselves. The innate immune system is often considered an effector of self-reactive lymphocytes, but also provides protection. Studies in mice with specific gene-directed mutations show that defects in innate immune system proteins may predispose to the development of a systemic lupus erythematosus-like syndrome (lupus) characterized by autoantibodies against double-stranded DNA (ds DNA) or nuclear components. This seems to be due to a failure in the removal of apoptotic cells or nuclear waste. These observations imply that the innate immune system has a general protective role against autoimmune disease. For example, in systemic diseases such as lupus, innate immunity is important in the elimination of nuclear antigens and, therefore, in the improvement of tolerance to B lymphocytes. Alternatively, in specific organ disorders such as type diabetes 1 o Crohn’s disease, the innate immune system can be protective by eliminating pathogens that trigger or exacerbate the disease or regulate the presentation of antigens for T lymphocytes. Discuss various disease models in which the innate immune system could provide a protective role, deficiencies in the regulation of B lymphocyte signaling through the antigen/receptor or in the clearance of lupus antigens, (dsDNA and nuclear proteins), can lead to a disease similar to lupus. The repertoire of B cells seems to be very biased toward self-activity, as, possibly, that of the T-cell. This tendency toward self-activity is not surprising because B and T cells are positively selected against highly conserved autoantigens.
Title: Innate Immunity and Autoimmune Diseases
Description:
The innate immune response is responsible for the initial defense against invading pathogens and signs of damage; in turn, it activates the adaptive immune response to result in highly specific and lasting immunity, mediated by the clonal expansion of antigen-specific B and T lymphocytes.
Inflammation is the acute response to infection and tissue damage to limit aggression to the body.
It is a complex reaction of vascularized tissues to infection, toxin exposure or cell injury that includes extravasation of plasma proteins and leukocytes.
Paradoxically, uncontrolled and prolonged inflammation can result in secondary damage and the development of immune pathology in the host.
The components of the innate immune system have recently been studied as responsible mechanisms in various chronic diseases such as diabetes mellitus, atherosclerosis, asthma and allergies, among others.
Autoimmune disease is an attack on auto tissues by the adaptation of the immune system.
In general, such diseases are characterized by autoantibodies and/or autoreactive lymphocytes directed at antigens against themselves.
The innate immune system is often considered an effector of self-reactive lymphocytes, but also provides protection.
Studies in mice with specific gene-directed mutations show that defects in innate immune system proteins may predispose to the development of a systemic lupus erythematosus-like syndrome (lupus) characterized by autoantibodies against double-stranded DNA (ds DNA) or nuclear components.
This seems to be due to a failure in the removal of apoptotic cells or nuclear waste.
These observations imply that the innate immune system has a general protective role against autoimmune disease.
For example, in systemic diseases such as lupus, innate immunity is important in the elimination of nuclear antigens and, therefore, in the improvement of tolerance to B lymphocytes.
Alternatively, in specific organ disorders such as type diabetes 1 o Crohn’s disease, the innate immune system can be protective by eliminating pathogens that trigger or exacerbate the disease or regulate the presentation of antigens for T lymphocytes.
Discuss various disease models in which the innate immune system could provide a protective role, deficiencies in the regulation of B lymphocyte signaling through the antigen/receptor or in the clearance of lupus antigens, (dsDNA and nuclear proteins), can lead to a disease similar to lupus.
The repertoire of B cells seems to be very biased toward self-activity, as, possibly, that of the T-cell.
This tendency toward self-activity is not surprising because B and T cells are positively selected against highly conserved autoantigens.
Related Results
Harnessing the microbiome to regulate systemic innate immunity
Harnessing the microbiome to regulate systemic innate immunity
Abstract
The mechanisms used by the gastrointestinal microbiome to regulate systemic immunity remain unclear. We have identified a microbiome Bacteroidota-derived li...
Abstract 2697: Simultaneous activation of innate immune suppressive components impairs antitumor efficacy of immunotherapy against the innate immune system
Abstract 2697: Simultaneous activation of innate immune suppressive components impairs antitumor efficacy of immunotherapy against the innate immune system
Abstract
Cancer immunotherapy has shown noticeable clinical efficacy in many cancer types, while clinical benefits are only observed in 20-40% of treated patients. T...
The causes and consequences of trained immunity in myeloid cells
The causes and consequences of trained immunity in myeloid cells
Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specif...
THE POTENTIAL OF GLP-1 IN THE TREATMENT OF AUTOIMMUNE DISEASES: A REVIEW OF MECHANISMS AND CLINICAL DATA
THE POTENTIAL OF GLP-1 IN THE TREATMENT OF AUTOIMMUNE DISEASES: A REVIEW OF MECHANISMS AND CLINICAL DATA
Introduction: Autoimmune diseases are a heterogeneous group of disorders characterized by dysregulated immune responses against self-antigens, leading to chronic inflammation and p...
Analysis of the causes and clinical course of thyroid diseases in the presence of autoimmune overlap syndrome
Analysis of the causes and clinical course of thyroid diseases in the presence of autoimmune overlap syndrome
In recent years, the prevalence of autoimmune thyroid diseases, particularly autoimmune thyroiditis and Graves’ disease, has increased. These conditions sometimes co‑occur as part ...
Intestinal Mucosal Immunity Caused Autoimmune Diseases
Intestinal Mucosal Immunity Caused Autoimmune Diseases
Autoimmune diseases are a group of chronic inflammatory disorders caused by the imbalance of immune homeostasis and abnormal production of autoantibodies. The etiology of autoimmun...
Abstract 1784: IL-7R targeting therapy for immunoregulation and overcoming steroid resistance in cancer and autoimmune disease
Abstract 1784: IL-7R targeting therapy for immunoregulation and overcoming steroid resistance in cancer and autoimmune disease
Abstract
The occurrence of autoimmune reactions caused by immune checkpoint blockade in the treatment of cancer indicates the importance of the cross-disciplinary st...
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
In recent years, the association of type 2 diabetes mellitus (DM) to autoimmune diseases has been discussed. Participation of innate immunity in the development of inflammation in ...

